Genetics & Genomics

Compared with other cancers, ovarian cancer is relatively rare, accounting for just 1.3% of all new cancer cases in the United States.

Jennifer R. Klemp, PhD, MPH presented “Genetics and Genomics: How Does Navigation Fit In?” at the Sixth Annual Academy of Oncology Nurse & Patient Navigators (AONN+) Conference in Atlanta, GA. “The real role of genomic medicine and where we’re going is that we do want to be more personalized,” Dr Klemp said. “The larger panel in genomic testing is going to keep taking us in that direction.”

In March, the National Comprehensive Cancer Network (NCCN) guidelines for genetic/familial high-risk assessment for breast and ovarian cancers were updated. Among the updates is a section on “gene panels.”